# The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome

Study · id `cardio:ct-nct01068093` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01068093](<https://clinicaltrials.gov/study/NCT01068093>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01068093

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT01068093. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2015-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT01068093, source copy `cardio:ctgov-nct01068093-2010-10-22`, retrieved 2026-10-26)
- Start date: 2010-10 (registry gives no type) (ClinicalTrials.gov record NCT01068093, source copy `cardio:ctgov-nct01068093-2010-10-22`, retrieved 2026-10-26)
- Primary completion: 2015-10 (anticipated) (ClinicalTrials.gov record NCT01068093, source copy `cardio:ctgov-nct01068093-2010-10-22`, retrieved 2026-10-26)
- Completion: 2015-10 (anticipated) (ClinicalTrials.gov record NCT01068093, source copy `cardio:ctgov-nct01068093-2010-10-22`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01068093, source copy `cardio:ctgov-nct01068093-2010-10-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01068093-2010-10-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome
- Condition: Coronary Artery Disease
- Intervention (Drug): Ezetimibe
- Lead sponsor: Yokohama City University Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Ezetimibe (`cardio:ezetimibe`)
- Registry lists this organization as the lead sponsor: Yokohama City University Medical Center (`cardio:org-yokohama-city-university-medical-center`)

## Provenance

Content hash: 76176eef0c6914dba4e6559e5b61c3bea1a6743870014387e8a576285efa2724
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
